HotSpot Therapeutics

HotSpot Therapeutics is dedicated to developing novel allosteric therapies for disease treatment. HotSpot Therapeutics has developed the proprietary SpotFinder technology platform, which enables the systematic discovery and targeting of allosteric sites that modulate protein function, and through targeting these sites, the development of first-in-class innovative drugs. HotSpot has established a top-tier small molecule pipeline for the treatment of cancer and autoimmune diseases, each achieved through precise and patient-focused clinical design.